FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570785250> ?p ?o ?g. }

• W2570785250 abstract "Immunotherapy with high-dose interleukin-2 (HD-IL2) results in long-term survival in some metastatic renal cell carcinoma (mRCC) patients but has significant acute toxicities. Biomarkers predicting response to therapy are needed to better select patients most likely to benefit. NLR (absolute neutrophil count (ANC)/absolute lymphocyte count (ALC)) is a prognostic and predicative biomarker in various malignancies. The goal was to determine whether NLR can predict response to HD-IL2 in this setting.Patients with clear cell mRCC treated with HD-IL2 were identified from an institutional database from 2003-2012. Baseline variables for the assessment of IMDC risk criteria, and neutrophil and lymphocyte count, were collected. Best response criteria were based on RECIST 1.0. Wilcoxon rank-sum test was used to evaluate the association of continuous baseline variables with disease control. NLR was stratified by ≤4 or >4. Progression free survival (PFS) and overall survival (OS) were estimated with the Kaplan-Meier method and Cox proportional hazard models assessed associations of NLR with survival.In 71 eligible patients, median NLR in those with an objective response (n = 14, 20%) was 2.3 vs 3.4 in those without (n = 57, 80%, p = 0.02). NLR ≤4 was associated with improved progression free and overall survival. After adjustment for IMDC risk criteria, NLR remained a significant predictor of OS (ANC/ALC ≤4 vs >4, HR 0.41, 95% CI 1.09-5.46, p = 0.03; ANC/ALC continuous variable per unit change in NLR, HR 1.08, 95% CI 1.01-1.14, p = 0.03).In this discovery set, NLR predicts overall survival in patients treated with HD-IL2 in mRCC, and may allow better patient selection in this setting. Data needs validation in an independent cohort." @default.
• W2570785250 created "2017-01-13" @default.
• W2570785250 creator A5004817395 @default.
• W2570785250 creator A5008891326 @default.
• W2570785250 creator A5024053204 @default.
• W2570785250 creator A5024065466 @default.
• W2570785250 creator A5059049062 @default.
• W2570785250 creator A5064795489 @default.
• W2570785250 creator A5069911187 @default.
• W2570785250 creator A5080507578 @default.
• W2570785250 creator A5088144108 @default.
• W2570785250 creator A5089235521 @default.
• W2570785250 date "2017-01-05" @default.
• W2570785250 modified "2023-10-14" @default.
• W2570785250 title "Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma" @default.
• W2570785250 cites W1430642159 @default.
• W2570785250 cites W1919200564 @default.
• W2570785250 cites W1987171792 @default.
• W2570785250 cites W1989925694 @default.
• W2570785250 cites W2003521616 @default.
• W2570785250 cites W2049345643 @default.
• W2570785250 cites W2051820020 @default.
• W2570785250 cites W2085458222 @default.
• W2570785250 cites W2099752220 @default.
• W2570785250 cites W2117692326 @default.
• W2570785250 cites W2123784879 @default.
• W2570785250 cites W2136636834 @default.
• W2570785250 cites W2180418594 @default.
• W2570785250 cites W2412808883 @default.
• W2570785250 cites W2816965188 @default.
• W2570785250 cites W946192996 @default.
• W2570785250 doi "https://doi.org/10.1186/s12894-016-0192-0" @default.
• W2570785250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5217571" @default.
• W2570785250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28056941" @default.
• W2570785250 hasPublicationYear "2017" @default.
• W2570785250 type Work @default.
• W2570785250 sameAs 2570785250 @default.
• W2570785250 citedByCount "28" @default.
• W2570785250 countsByYear W25707852502017 @default.
• W2570785250 countsByYear W25707852502018 @default.
• W2570785250 countsByYear W25707852502019 @default.
• W2570785250 countsByYear W25707852502020 @default.
• W2570785250 countsByYear W25707852502021 @default.
• W2570785250 countsByYear W25707852502022 @default.
• W2570785250 countsByYear W25707852502023 @default.
• W2570785250 crossrefType "journal-article" @default.
• W2570785250 hasAuthorship W2570785250A5004817395 @default.
• W2570785250 hasAuthorship W2570785250A5008891326 @default.
• W2570785250 hasAuthorship W2570785250A5024053204 @default.
• W2570785250 hasAuthorship W2570785250A5024065466 @default.
• W2570785250 hasAuthorship W2570785250A5059049062 @default.
• W2570785250 hasAuthorship W2570785250A5064795489 @default.
• W2570785250 hasAuthorship W2570785250A5069911187 @default.
• W2570785250 hasAuthorship W2570785250A5080507578 @default.
• W2570785250 hasAuthorship W2570785250A5088144108 @default.
• W2570785250 hasAuthorship W2570785250A5089235521 @default.
• W2570785250 hasBestOaLocation W25707852501 @default.
• W2570785250 hasConcept C126322002 @default.
• W2570785250 hasConcept C143998085 @default.
• W2570785250 hasConcept C185592680 @default.
• W2570785250 hasConcept C207103383 @default.
• W2570785250 hasConcept C2777063308 @default.
• W2570785250 hasConcept C2777472916 @default.
• W2570785250 hasConcept C2777761686 @default.
• W2570785250 hasConcept C2778822529 @default.
• W2570785250 hasConcept C2778963024 @default.
• W2570785250 hasConcept C2779134260 @default.
• W2570785250 hasConcept C2779984678 @default.
• W2570785250 hasConcept C2780739268 @default.
• W2570785250 hasConcept C2781197716 @default.
• W2570785250 hasConcept C29730261 @default.
• W2570785250 hasConcept C3019894029 @default.
• W2570785250 hasConcept C44249647 @default.
• W2570785250 hasConcept C50382708 @default.
• W2570785250 hasConcept C55493867 @default.
• W2570785250 hasConcept C71924100 @default.
• W2570785250 hasConcept C74133956 @default.
• W2570785250 hasConcept C90924648 @default.
• W2570785250 hasConceptScore W2570785250C126322002 @default.
• W2570785250 hasConceptScore W2570785250C143998085 @default.
• W2570785250 hasConceptScore W2570785250C185592680 @default.
• W2570785250 hasConceptScore W2570785250C207103383 @default.
• W2570785250 hasConceptScore W2570785250C2777063308 @default.
• W2570785250 hasConceptScore W2570785250C2777472916 @default.
• W2570785250 hasConceptScore W2570785250C2777761686 @default.
• W2570785250 hasConceptScore W2570785250C2778822529 @default.
• W2570785250 hasConceptScore W2570785250C2778963024 @default.
• W2570785250 hasConceptScore W2570785250C2779134260 @default.
• W2570785250 hasConceptScore W2570785250C2779984678 @default.
• W2570785250 hasConceptScore W2570785250C2780739268 @default.
• W2570785250 hasConceptScore W2570785250C2781197716 @default.
• W2570785250 hasConceptScore W2570785250C29730261 @default.
• W2570785250 hasConceptScore W2570785250C3019894029 @default.
• W2570785250 hasConceptScore W2570785250C44249647 @default.
• W2570785250 hasConceptScore W2570785250C50382708 @default.
• W2570785250 hasConceptScore W2570785250C55493867 @default.
• W2570785250 hasConceptScore W2570785250C71924100 @default.
• W2570785250 hasConceptScore W2570785250C74133956 @default.
• W2570785250 hasConceptScore W2570785250C90924648 @default.
• W2570785250 hasIssue "1" @default.

• next